Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT03050762

Conditions

Endocrine Disease

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Data Collection

Follow Up

Study Details

Brief summary:

The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.

Conditions

Endocrine Disease

Study ID

NCT03050762

Start date

Oct 5, 2011

Status verified date

Sep, 2019

Completion date

Oct, 2027

Anticipated

Primary completion date

Oct, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. All patients that are being seen at MD Anderson with diagnosed or suspected endocrine disease. Patients will be selected from patients undergoing evaluation and/or treatment in the Endocrine Center, either by selection from a participating Endocrine physician or by screening from study personnel for patients scheduled to be seen in the Endocrine Clinic.
2. In addition, we intend to contact family members of patients who are enrolled on the study, and found to be deceased at follow-up, to request permission to obtain cause of death, to determine whether cause of death may be related to endocrine disease.

Exclusion Criteria:

N/A

Study Design

Enrollment

15000 participants

Anticipated

Interventions and Outcome Measures

Arms

Endocrine Disease Group

Information from the medical record recorded and entered into a research database.

Starting about 2-3 years after testing and/or diagnosis and/or treatment and continuing for up to 15 years after surgery, research team will contact participant by phone to follow up.

Interventions

Data Collection

Participant information collected from either source document or direct participant response.

Follow Up

Participants followed up at the return to clinic visits. If participant cannot come to clinic, either a questionnaire mailed requesting follow-up, or participant called. Participants followed for a length of 15 years at intervals of every 2-3 years.

Primary outcome measure

  • Research Database Compilation from Suspected or Diagnosed Endocrine Disease Participants by Medical Record Review and Follow Up [ Time Frame: 15 years ]

Central Contacts and Locations

Central contacts

Nancy D. Perrier, MD

713-792-6940NPerrier@mdanderson.org

Locations

University of Texas MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Sep 17, 2019

Last verified

Sep, 2019

Keywords

  • Endocrine Disease
  • Thyroid disease
  • Parathyroid disease
  • Adrenal disease
  • Data Review
  • Database

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2019-09-17.